INSIGHTS ON PHARMACEUTICAL PACKAGING
-
FAQs On The Revised EU GMP Annex 1: Volume 1
The revised GMP Annex 1 guidelines emphasize quality risk management, enhanced environmental monitoring, and data integrity, which aim to minimize contamination and ensure patient safety.
-
Supporting GLP-1 And Peptides With Integrated Solutions
Accelerate GLP-1 and peptide therapy development with integrated drug containment, delivery, machinery, and analytics for reliable combination product performance.
-
Why A Leading Manufacturing Partner Chose NeoTOP Packaging Machines
Learn how a leading CDMO partnered with Körber to quickly deploy a high-speed packaging solution to meet tight production deadlines in the face of a global pandemic.
-
Key Considerations When Developing Your Combination Product
Succeed in combination product development by understanding the risk factors that may arise and implementing mitigation strategies that will streamline the device development process.
-
Providing Packing And Blinding Solutions For An Innovative Drug Start-Up9/13/2024
Discover how a CDMO with integrated services enabled a botanical drug start-up to commence its Phase 1 clinical trial, paving the way for further advancement of its innovative botanical drug.
-
Designing Robust Studies To Meet Auto-Injector Performance Requirements10/30/2025
Learn more about the critical tests for ensuring the proper performance of auto-injectors, which are used for a variety of applications ranging from emergency use to treating chronic conditions.
-
Bridging The Gap Between Product Readiness And Equipment Availability12/15/2025
Discover how manual precision at scale bridges packaging gaps, accelerates product launches, and ensures uninterrupted supply to deliver quality when automated equipment isn’t yet operational.
-
Determining The Limit Of Detection In CCIT12/18/2025
Accurately determining the smallest detectable defect in pharmaceutical packaging is essential for sterility. Learn how test sensitivity, positive controls, and regulatory standards shape CCI strategies.
-
Importance Of Assessing Mannitol Crystallinity In Lyophilized Drug Products10/16/2024
Drug product stability may be seriously compromised if mannitol completes crystallization during storage rather than during the freezing or annealing step in the lyophilization process.
PHARMACEUTICAL PACKAGING SOLUTIONS
-
Weiler Engineering’s ASEP-TECH® Blow/Fill/Seal machines are ideal for processing temperature sensitive products such as biological and protein-based materials – providing a level of enhanced sterility assurance.
-
PCI provides a comprehensive service at each stage of the product lifecycle for a wide range of dosage forms, in full compliance with GMP regulatory standards for both highly potent and non-potent drug products.
-
As pharmaceutical companies seek to streamline early phase development to establish proof of concept quickly and efficiently, PCI’s Speed to StudyTM services are designed to manoeuvre complex trial designs with maximized flexibility and speed.
-
Ropack's portfolio of primary pharmaceutical packaging methods meets the highest quality and safety standards.
-
Seal-Sensor detects incomplete seals, partial or weak areas in seals, and many common defects in seals that appear visually acceptable yet possess defects that affect product quality, value, and shelf-life.